688238 和元生物
已收盘 08-17 15:00:01
资讯
新帖
简况
创新药板块异动拉升，和元生物大涨超15%
证券之星 · 08-07
创新药板块异动拉升，和元生物大涨超15%
和元生物（688238）披露全资子公司拟申请3.9亿元授信并由公司提供连带责任担保公告，7月23日股价下跌0.18%
证券之星 · 07-23
和元生物（688238）披露全资子公司拟申请3.9亿元授信并由公司提供连带责任担保公告，7月23日股价下跌0.18%
股市必读：和元生物（688238）7月22日董秘有最新回复
证券之星 · 07-23
股市必读：和元生物（688238）7月22日董秘有最新回复
和元生物：二级市场股价受多方面因素综合影响
证券之星 · 07-22
和元生物：二级市场股价受多方面因素综合影响
和元生物（688238）628.74万股限售股将于7月20日解禁，占总股本0.97%
证券之星 · 07-20
和元生物（688238）628.74万股限售股将于7月20日解禁，占总股本0.97%
和元生物（688238）披露2025年限制性股票激励计划预留权益失效公告，7月17日股价下跌9.55%
证券之星 · 07-17
和元生物（688238）披露2025年限制性股票激励计划预留权益失效公告，7月17日股价下跌9.55%
和元生物荣获证券之星“碳路践行者奖”
证券之星 · 07-17
和元生物荣获证券之星“碳路践行者奖”
每周股票复盘：和元生物（688238）登龙虎榜，CDMO订单增厚
证券之星 · 07-12
每周股票复盘：和元生物（688238）登龙虎榜，CDMO订单增厚
和元生物（688238）披露2025年年报问询函回复公告，7月10日股价上涨16.7%
证券之星 · 07-10
和元生物（688238）披露2025年年报问询函回复公告，7月10日股价上涨16.7%
7月10日和元生物（688238）龙虎榜数据：机构净卖出2049.75万元
证券之星 · 07-10
7月10日和元生物（688238）龙虎榜数据：机构净卖出2049.75万元
CGT产业迎重磅政策，和元生物股价20CM涨停
证券之星 · 07-10
CGT产业迎重磅政策，和元生物股价20CM涨停
异动快报：和元生物（688238）7月10日9点57分触及涨停板
证券之星 · 07-10
异动快报：和元生物（688238）7月10日9点57分触及涨停板
股市必读：和元生物（688238）7月6日披露最新机构调研信息
证券之星 · 07-07
股市必读：和元生物（688238）7月6日披露最新机构调研信息
和元生物：6月23日组织现场参观活动，东方证券、投资者参与
证券之星 · 07-06
和元生物：6月23日组织现场参观活动，东方证券、投资者参与
CGT产业再迎重磅政策 审评审批效率大幅提升
经济参考网 · 07-06
CGT产业再迎重磅政策 审评审批效率大幅提升
每周股票复盘：和元生物（688238）2026年力争完成C证取证
证券之星 · 06-20
每周股票复盘：和元生物（688238）2026年力争完成C证取证
【私募调研记录】天戈投资调研和元生物、初灵信息
证券之星 · 06-19
【私募调研记录】天戈投资调研和元生物、初灵信息
和元生物（688238）披露董事会秘书变更及高级管理人员变动公告，6月2日股价上涨0.49%
证券之星 · 06-02
和元生物（688238）披露董事会秘书变更及高级管理人员变动公告，6月2日股价上涨0.49%
每周股票复盘：和元生物（688238）2025年度股东会多项议案获通过
证券之星 · 05-17
每周股票复盘：和元生物（688238）2025年度股东会多项议案获通过
和元生物（688238）披露2025年年度股东会决议公告，5月14日股价下跌2.44%
证券之星 · 05-14
和元生物（688238）披露2025年年度股东会决议公告，5月14日股价下跌2.44%
公司概况
公司名称：
上海和元生物技术(集团)股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-03-22
主营业务：
上海和元生物技术(集团)股份有限公司的主营业务是各类细胞和基因治疗CRO服务及CDMO服务。公司的主要产品是基因治疗载体研制服务、基因功能研究服务、基因检测服务、新药Pre-IND服务、新药Post-IND服务、再生医学制备服务、细胞存储及配套服务、生物原料、生物制剂产品、试剂、试剂盒及其他产品。
发行价格：
13.23
{"stockData":{"symbol":"688238","market":"SH","secType":"STK","nameCN":"和元生物","latestPrice":7.34,"timestamp":1786950001000,"preClose":7.5,"halted":0,"volume":29446385,"delay":0,"changeRate":-0.0213,"floatShares":647000000,"shares":649000000,"eps":-0.3524,"marketStatus":"已收盘","change":-0.16,"latestTime":"08-17 15:00:01","open":7.43,"high":7.53,"low":7.15,"amount":216000000,"amplitude":0.0507,"askPrice":7.35,"askSize":826,"bidPrice":7.34,"bidSize":335,"shortable":0,"etf":0,"ttmEps":-0.3524,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787016600000},"marketStatusCode":5,"adr":0,"adjPreClose":7.5,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786930200000,1786937400000],[1786942800000,1786950000000]],"highLimit":8.25,"lowLimit":6.75,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":649036700,"isCdr":false,"pbRate":3.51,"roa":"--","roe":"--","epsLYR":-0.37,"committee":-0.035513,"marketValue":4764000000,"turnoverRate":0.0455,"status":1,"afterMarket":{"amount":0,"volume":0,"close":7.34,"buyVolume":200,"sellVolume":0,"time":1786952037746,"indexStatus":"已收盘 08-17 15:30:00","preClose":7.5},"floatMarketCap":4752000000},"requestUrl":"/m/hq/s/688238/wiki","defaultTab":"wiki","newsList":[{"id":"2657459694","title":"创新药板块异动拉升，和元生物大涨超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657459694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657459694?lang=zh_cn&edition=full","pubTime":"2026-08-07 14:23","pubTimestamp":1786083834,"startTime":"0","endTime":"0","summary":"8月7日，创新药及CXO板块异动拉升，截至发稿，和元生物上涨15.38%，报6.90元，换手率5.85%，成交额2.45亿元。消息面上，今日生物制品、创新药及CRO方向集体走强，早盘上证科创板生物医药指数一度上涨2.62%，医药产业链风险偏好明显回升。兴业证券8月医药月报指出，全球创新药及产业链景气度维持高位，多家海外跨国药企与CXO企业披露中报盈喜并上调全年指引。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026080700020357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK1161","159992","06978","BK0216","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653844729","title":"和元生物（688238）披露全资子公司拟申请3.9亿元授信并由公司提供连带责任担保公告，7月23日股价下跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653844729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653844729?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:32","pubTimestamp":1784817139,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，和元生物报收于5.66元，较前一交易日下跌0.18%，最新总市值为36.74亿元。该股当日开盘5.67元，最高5.75元，最低5.47元，成交额达1.09亿元，换手率为3.01%。近日，和元生物披露《2026年第二次临时股东会会议资料》公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300048196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653672917","title":"股市必读：和元生物（688238）7月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653672917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653672917?lang=zh_cn&edition=full","pubTime":"2026-07-23 02:33","pubTimestamp":1784745238,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，和元生物报收于5.67元，下跌0.87%，换手率3.31%，成交量21.42万手，成交额1.25亿元。董秘最新回复投资者： 尊敬的董秘，你好！最近国家出台了很多利好于和元生物的政策，相信公司未来会越来越好，但是公司股价长期萎靡不振，很多投资者对公司股票走势不看好，请问公司是否可以出台一些提振股价的措施呢？当日关注点交易信息汇总：7月22日主力资金净流出71.53万元，游资资金净流入936.61万元，散户资金净流出865.08万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300002619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653990759","title":"和元生物：二级市场股价受多方面因素综合影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2653990759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653990759?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:06","pubTimestamp":1784714777,"startTime":"0","endTime":"0","summary":"最近国家出台了很多利好于和元生物的政策，相信公司未来会越来越好，但是公司股价长期萎靡不振，很多投资者对公司股票走势不看好，请问公司是否可以出台一些提振股价的措施呢？二级市场股价受多方面因素综合影响，公司高度重视市值管理工作，目前主要立足于做好主营业务，持续加强经营管理质量，优化公司合规治理，夯实投资者关系，规范运作，保持公司的健康发展，提高公司的投资价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200037531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652847263","title":"和元生物（688238）628.74万股限售股将于7月20日解禁，占总股本0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652847263","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652847263?lang=zh_cn&edition=full","pubTime":"2026-07-20 08:02","pubTimestamp":1784505735,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，和元生物于7月20日将有628.74万股限售股份解禁，为公司股权激励期权行权，占公司总股本0.97%。本次解禁后，公司还有160.36万股限售股份，占总股本0.25%。本文数据来源于和元生物公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000001894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652286019","title":"和元生物（688238）披露2025年限制性股票激励计划预留权益失效公告，7月17日股价下跌9.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652286019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652286019?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:12","pubTimestamp":1784297543,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，和元生物报收于5.97元，较前一交易日下跌9.55%，最新总市值为38.75亿元。该股当日开盘6.58元，最高6.58元，最低5.96元，成交额达2.13亿元，换手率为5.34%。近日，上海和元生物技术（集团）股份有限公司发布《关于2025年限制性股票激励计划预留权益失效的公告》。公告显示，公司2025年限制性股票激励计划中预留的749,000股限制性股票，因在股东会审议通过后12个月内未明确授予对象，根据相关规定已失效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652283242","title":"和元生物荣获证券之星“碳路践行者奖”","url":"https://stock-news.laohu8.com/highlight/detail?id=2652283242","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652283242?lang=zh_cn&edition=full","pubTime":"2026-07-17 20:48","pubTimestamp":1784292518,"startTime":"0","endTime":"0","summary":"7月17日，以“创新·共治·致远”为主题的2026证券之星ESG年度研讨会暨第四届ESG新标杆企业奖颁奖典礼在上海举行。上海和元生物技术(集团)股份有限公司凭借绿色运营、节能技改与细胞基因治疗产业服务实践，荣获“碳路践行者奖”。报告期内，公司废气、废水、固体废物、噪声排放合规率100%，未发生重大环境事件或重大行政处罚。截至报告期末，公司董事会共9名成员，其中女性董事3名，独立董事4名；战略与ESG委员会召开3次会议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026071700042179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","161027","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650714151","title":"每周股票复盘：和元生物（688238）登龙虎榜，CDMO订单增厚","url":"https://stock-news.laohu8.com/highlight/detail?id=2650714151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650714151?lang=zh_cn&edition=full","pubTime":"2026-07-12 01:42","pubTimestamp":1783791733,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，和元生物报收于6.71元，较上周的5.82元上涨15.29%。来自公司公告汇总：和元生物2025年CDMO业务毛利率为-79.17%。交易信息汇总和元生物于2026年7月10日因有价格涨跌幅限制的日收盘价格涨幅达到15%进入上交所龙虎榜，为近5个交易日内首次上榜。和元生物2025年实现营业收入26,769.69万元，同比增长7.88%，第四季度收入大幅增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650355241","title":"和元生物（688238）披露2025年年报问询函回复公告，7月10日股价上涨16.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650355241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650355241?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:13","pubTimestamp":1783692794,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，和元生物报收于6.71元，较前一交易日上涨16.7%，最新总市值为43.55亿元。该股当日开盘5.85元，最高6.9元，最低5.8元，成交额达4.66亿元，换手率为10.84%。近日，和元生物发布《关于2025年年度报告的信息披露监管问询函的回复公告》。公告显示，公司就2025年年度报告收到上交所监管问询函，针对营业收入季节性波动、毛利率为负、应收账款增长、固定资产减值及货币资金下降等问题作出回复。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650318607","title":"7月10日和元生物（688238）龙虎榜数据：机构净卖出2049.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650318607","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650318607?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:29","pubTimestamp":1783675754,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月10日公布的交易公开信息显示，和元生物因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月10日收盘，和元生物报收于6.71元，上涨16.7%，换手率10.84%，成交量69.5万手，成交额4.66亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出2049.75万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000031624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650909883","title":"CGT产业迎重磅政策，和元生物股价20CM涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2650909883","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650909883?lang=zh_cn&edition=full","pubTime":"2026-07-10 11:19","pubTimestamp":1783653562,"startTime":"0","endTime":"0","summary":"7月10日，和元生物股价大涨，截至发稿，公司股价实现20CM涨停。深耕CGT CDMO领域多年的和元生物，已搭建起覆盖质粒、病毒载体、细胞治疗三大技术平台的GMP生产体系，累计服务数百个CGT项目，在溶瘤病毒等领域形成差异化优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026071000015316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650790546","title":"异动快报：和元生物（688238）7月10日9点57分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2650790546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650790546?lang=zh_cn&edition=full","pubTime":"2026-07-10 10:01","pubTimestamp":1783648862,"startTime":"0","endTime":"0","summary":"证券之星7月10日盘中消息，9点57分和元生物（688238）触及涨停板。其所属行业医疗服务目前上涨。领涨股为和元生物。该股为基因编辑，CAR-T疗法，干细胞概念热股，当日基因编辑概念上涨4.11%，CAR-T疗法概念上涨3.3%，干细胞概念上涨3.24%。7月9日的资金流向数据方面，主力资金净流出419.24万元，占总成交额3.92%，游资资金净流入765.54万元，占总成交额7.15%，散户资金净流出346.31万元，占总成交额3.23%。近5日资金流向一览见下表：和元生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000010466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649673293","title":"股市必读：和元生物（688238）7月6日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2649673293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649673293?lang=zh_cn&edition=full","pubTime":"2026-07-07 01:09","pubTimestamp":1783357751,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，和元生物报收于6.35元，上涨9.11%，换手率7.56%，成交量48.44万手，成交额3.13亿元。机构调研要点6月23日我是股东走进上市公司-和元生物,现场参观调研交流2026年6月23日下午，东方证券联合20余名投资者在和元生物举办“我是股东—走进上市公司”活动。公司披露：截至2026年一季度末，新增CDMO订单超过5,600万元；累计协助客户获得国内外IND批件70个，其中美国FDA批件15个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700000594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649362907","title":"和元生物：6月23日组织现场参观活动，东方证券、投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2649362907","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649362907?lang=zh_cn&edition=full","pubTime":"2026-07-06 20:10","pubTimestamp":1783339854,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年7月6日和元生物发布公告称公司于2026年6月23日组织现场参观活动，东方证券相关人员、投资者参与。答：2026年 6月 23日下午，东方证券联合投资者在和元生物举办了“我是股东—走进上市公司”活动，20 余名投资者走进公司进行深度调研。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600033326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0276","BK0188","688238","BK0028","BK0183","600958","BK0216","BK1147","BK1564","03958"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649645294","title":"CGT产业再迎重磅政策 审评审批效率大幅提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2649645294","media":"经济参考网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649645294?lang=zh_cn&edition=full","pubTime":"2026-07-06 14:00","pubTimestamp":1783317615,"startTime":"0","endTime":"0","summary":"近日，国家药监局综合司发布《关于优化细胞与基因治疗药品审评审批有关事项的公告（征求意见稿）》，核心内容为将符合条件的细胞与基因治疗（CGT）药品纳入创新药临床试验审评审批30日通道，提高临床研发质效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607063795032240.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607063795032240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK0216","300759","IBBQ","688238","BK0028","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644065874","title":"每周股票复盘：和元生物（688238）2026年力争完成C证取证","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644065874?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:48","pubTimestamp":1781894891,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，和元生物报收于5.55元，较上周的5.35元上涨3.74%。本周，和元生物6月18日盘中最高价报5.7元。和元生物当前最新总市值36.02亿元，在医疗服务板块市值排名37/51，在两市A股市值排名3973/5206。本周关注点来自机构调研要点：公司力争2026年顺利完成药品生产许可证（C证）取证。来自机构调研要点：2026年第一季度，公司累计新增CDMO业务订单超过5,600万元。截至2026年一季度末，累计协助客户获得国内外IND批件70个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644032133","title":"【私募调研记录】天戈投资调研和元生物、初灵信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2644032133","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644032133?lang=zh_cn&edition=full","pubTime":"2026-06-19 08:01","pubTimestamp":1781827266,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月18日披露的机构调研信息，知名私募天戈投资近期对2家上市公司进行了调研，相关名单如下：1）和元生物 调研纪要：公司正稳步推进药品生产许可证（C证）申请，力争2026年完成取证。2025年中国CGT领域融资总额约21.78亿美元，同比增长237.15%。公司参与设立5亿元规模CGT产业并购基金，拟出资不超1亿元。公司业务范围包括投资管理、资产管理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026061900004833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0148","BK0090","BK0028","300250","BK0111","BK0216","688238","BK0231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911548","title":"和元生物（688238）披露董事会秘书变更及高级管理人员变动公告，6月2日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911548","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640911548?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:44","pubTimestamp":1780393482,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，和元生物报收于6.11元，较前一交易日上涨0.49%，最新总市值为39.66亿元。该股当日开盘6.08元，最高6.27元，最低6.01元，成交额达1.01亿元，换手率为2.56%。近日，和元生物披露《关于董事会秘书变更及高级管理人员变动的公告》。公告显示，公司董事会于2026年5月29日收到副总经理、董事会秘书徐鲁媛女士，副总经理殷珊女士、吴钦斌女士的书面辞呈。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200034896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636624300","title":"每周股票复盘：和元生物（688238）2025年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2636624300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636624300?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:47","pubTimestamp":1778964429,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，和元生物报收于6.32元，较上周的6.65元下跌4.96%。本周，和元生物5月11日盘中最高价报6.84元。5月15日盘中最低价报6.27元。本周关注点公司公告汇总：和元生物2025年年度股东会于2026年5月13日召开，各项议案均获通过。公司公告汇总上海市金茂律师事务所就上海和元生物技术(集团)股份有限公司2025年年度股东会的召集、召开程序、出席会议人员资格、表决程序及表决结果出具法律意见书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635718766","title":"和元生物（688238）披露2025年年度股东会决议公告，5月14日股价下跌2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635718766","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635718766?lang=zh_cn&edition=full","pubTime":"2026-05-14 17:49","pubTimestamp":1778752156,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，和元生物报收于6.39元，较前一交易日下跌2.44%，最新总市值为41.47亿元。该股当日开盘6.54元，最高6.63元，最低6.38元，成交额达6020.66万元，换手率为1.46%。和元生物于近日披露《2025年年度股东会决议公告》。会议表决程序合法，所有议案均获通过，无被否决议案。中小投资者对部分议案进行了单独计票，关联股东对关联交易等相关议案回避表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400033828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786984266420,"stockEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":0.2295},{"period":"3month","weight":0.138},{"period":"6month","weight":0.0353},{"period":"1year","weight":-0.0836},{"period":"ytd","weight":0.1021}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.058},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.0244},{"period":"1year","weight":0.0773},{"period":"ytd","weight":0.0035}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海和元生物技术(集团)股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"14931人(较上一季度增加6.65%)","perCapita":"43361股","listingDate":"2022-03-22","address":"上海市浦东新区国际医学园区紫萍路908弄19号楼","registeredCapital":"64903万元","survey":" 上海和元生物技术(集团)股份有限公司的主营业务是各类细胞和基因治疗CRO服务及CDMO服务。公司的主要产品是基因治疗载体研制服务、基因功能研究服务、基因检测服务、新药Pre-IND服务、新药Post-IND服务、再生医学制备服务、细胞存储及配套服务、生物原料、生物制剂产品、试剂、试剂盒及其他产品。","listedPrice":13.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和元生物,688238,和元生物股票,和元生物股票老虎,和元生物股票老虎国际,和元生物行情,和元生物股票行情,和元生物股价,和元生物股市,和元生物股票价格,和元生物股票交易,和元生物股票购买,和元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}